Britain’s GlaxoSmithKline agreed to buy American biotech firm Tesaro for $5 billion. US local TV operator Nexstar is looking to bulk up with a $4 billion acquisition of rival Tribune. <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Britain’s GlaxoSmithKline agreed to buy American biotech firm Tesaro for $5 billion. US local TV operator Nexstar is looking to bulk up with a $4 billion acquisition of rival Tribune. See acast.com/privacy for privacy and opt-out information.

Britain’s GlaxoSmithKline agreed to buy American biotech firm Tesaro for $5 billion. US local TV operator Nexstar is looking to bulk up with a $4 billion acquisition of rival Tribune. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for privacy and opt-out information.

Tuesday, 4th Dec. - GlaxoSmith-De-Kline

The top two bits of financial news brought to you in plain English every weekday morning. Five minutes and you're caught up. Finimize is all you need. <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Business

News

Daily News

Business News

The top two bits of financial news brought to you in plain English every weekday morning. Five minutes and you're caught up. Finimize is all you need. See acast.com/privacy for privacy and opt-out information.

The top two bits of financial news brought to you in plain English every weekday morning. Five minutes and you're caught up. Finimize is all you need. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for privacy and opt-out information.

Share Tuesday, 4th Dec. - GlaxoSmith-De-Kline

Sign up to save your podcasts

Tuesday, 4th Dec. - GlaxoSmith-De-Kline

Tuesday, 4th Dec. - GlaxoSmith-De-Kline